inhibitors - inhibitors Manufacturer Supplier Exporter

Price

Supplier Type

Manufacturer
Trader
Reagent
contract manufacturer
custom synthesis

Supplier Region

Hyderabad(10)
Gujarat(12)
Mumbai(19)
Maharashtra(18)
Telangana(1)
Bangalore(1)
Ahmedabad(3)
Nagpur(1)
Haryana(2)
Tamil Nadu(2)
New Delhi(2)
Uttar Pradesh(4)
Vadodara(2)
Pune(1)
Delhi(2)
Karnataka(2)
Beijing(1)
Andhra Pradesh(1)

Purity

Z-VAD-FMK, CAS 187389-52-2, is a cell-permeable, irreversible, pan-caspase inhibitor.
VETRANAL?, analytical standard
United States Pharmacopeia (USP) Reference Standard
The AhR Antagonist, also referenced under CAS 301326-22-7, controls the biological activity of AhR.
synthetic, ≥90% (HPLC)
solid, ≥98% (HPLC)
solid
reference standard
puriss. p.a., absolute, ≥99.5% (GC)
powder
Potent, reversible, and cell-permeable proteasome inhibitor (Ki = 4 nM).
pharmaceutical secondary standard, certified reference material
Pharmaceutical Secondary Standard
NLT 95%
Min. 99%
LRRK2-IN-1 primarily used in Inhibition.
InSolution,≥95%
InSolution, ≥98%, 50 mM in DMSO, A cell-permeable benzodiazepine compound
InSolution, ≥98%, 5 mg/ml, reversible inhibitor of MAP Kinase Kinase (MEK)
InSolution, ≥98%, 25 mM in DMSO
InSolution, ≥98%, 10 mM, reversible proteasome inhibitor
InSolution, ≥98%, 10 mM, reversible and specific inhibitor of PI 3-kinase
InSolution, ≥98%, 1 mg/ml, reversible inhibitor of p38 MAP kinase
InSolution, ≥97%, 25 mM in DMSO
InSolution, ≥95%, protein kinase C (PKC) inhibitor
InSolution, ≥95%, Inhibitor of protein kinase C
InSolution, ≥95%, inhibitor of cyclin-dependent kinases (CDKs)
InSolution, ≥95%
IC?? = 800 nM).
Hesperadin primarily used in Inhibition.
HCl 98%
Greater than 99%
European Pharmacopoeia (EP) Reference Standard
Certified Reference Material
British Pharmacopoeia (BP) Reference Standard
BioReagent, suitable for fluorescence, ≥96.0% (HPLC)
Batimastat primarily used in Inhibition.
analytical standard
AldrichCPR
A potent inhibitor of HDACs and receptor tyrosine kinases
A novel anti-neoplastic agent and transcriptional regulator.
A cell-permeable, selective inhibitor of cAMP-specific phosphodiesterase (PDE IV
A cell-permeable, potent, reversible proteasome inhibitor (Ki = 4 nM).
A cell-permeable piperazinyl-quinazolinone compound that exhibits oncogene-selective lethality.
99.94%
99.9%
99.66%
≥99.5%
99.5%
99.10%
≥99.0% (NT)
99%+
≥99%, crystalline
99% purity
99% (HPLC Tested)
99% (High-quality, pharmaceutical grade)
99%
>99%
98+
98.50%
98.42%
98.32%
98.0-102.0%, solid
98.00%
>98.0%(T)(HPLC)
>98.0%(T)
>98.0%(HPLC)(N)
>98.0%(HPLC)
>98.0%(GC)
≥98% (TLC)
≥98% (HPLC), white to off-white, powder
>98% (HPLC), solid
≥98% (HPLC), solid
≥98% (HPLC), powder
≥98% (HPLC)
>98% (HPLC)
98%
>98%
98 %
97-99%
>97.0%(N)
>97.0%(HPLC)(N)
>97.0%(HPLC)
≥97% (HPLC), solid
≥97% (HPLC)
97%
95.00%
>95.0%(T)(HPLC)
>95.0%(HPLC)
≥95%, powder
≥95% (HPLC), powder
>95% (HPLC)
≥95% (HPLC)
>90.0%(HPLC)
≥90% (HPLC)
90 % Above
100%
1.0?mg/mL in methanol, ampule of 1?mL, certified reference material, Cerilliant?
1.0?mg/mL in methanol (as free base), ampule of 1?mL, certified reference material, Cerilliant?
&ge